Equities

Shanghai Haixin Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shanghai Haixin Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.284
  • Today's Change0.001 / 0.35%
  • Shares traded908.05k
  • 1 Year change-0.35%
  • Beta1.1302
Data delayed at least 15 minutes, as of Feb 12 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Shanghai Haixin Group Co Ltd is a China-based diversified investment holding group that integrates pharmaceuticals, property leasing and management, textiles, and financial investment. The Company consists of five business segments. The main business and assets of the Investment segment are foreign investment. The Textile segment is mainly engaged in textile fabrics and clothing. The Medical segment is mainly engaged in the production and sales of pharmaceuticals, mainly chemical drugs. The Trading segment is mainly engaged in commodity goods trading. The Industrial Park segment is mainly engaged in real estate leasing and property management. The Company conducts business in the domestic market.

  • Revenue in CNY (TTM)788.05m
  • Net income in CNY156.25m
  • Incorporated1993
  • Employees715.00
  • Location
    Shanghai Haixin Group Co LtdNo.688 Changxing RoadDongjing Town, Songjiang DistrictSHANGHAI 200001ChinaCHN
  • Phone+86 2 163917000
  • Fax+86 2 163917678
  • Websitehttps://www.haixin.com
More ▼

Institutional shareholders

7.33%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202520.16m4.30%
Chongqing International Trust Co., Ltd.as of 30 Sep 202512.63m2.69%
Vanguard Fiduciary Trust Co.as of 30 Nov 20251.34m0.29%
SSgA Funds Management, Inc.as of 08 Jan 2026150.71k0.03%
Vanguard Asset Management Ltd.as of 31 Dec 202588.74k0.02%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.